Researcher Next
Create account
← Back to directory

Do‐Youn Oh

Researcher Next ID · RN-005736

Researcher · Medicine

Seoul National University

Seoul, South Korea

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
958
Citation count
45,349
H-index
82
i10-index
385

Research interests

Medicine
Cholangiocarcinoma and Gallbladder Cancer Studies
Gastric Cancer Management and Outcomes
Pancreatic and Hepatic Oncology Research
HER2/EGFR in Cancer Research
Colorectal Cancer Treatments and Studies

Publications

  • Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study

    The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30109-1

  • Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1903387

  • Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)31827-5

  • Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

    The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)00817-x

  • Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

    New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1209124

Current projects

    No projects listed.